Neoantigen Cancer Vaccines Infographic
This infographic covers
- Number of assets in each trial phase and, the typical pattern that emerges when looking at the highest phase of development
- Clinical growth through the distribution of the number of trials over time
- Trials that have been withdrawn since 2011 with reasoning
You May Also Be Interested In…
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
